Free Trial

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Acquired by Fuller & Thaler Asset Management Inc.

DENTSPLY SIRONA logo with Medical background

Fuller & Thaler Asset Management Inc. lifted its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 2.8% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 11,539,418 shares of the medical instruments supplier's stock after purchasing an additional 314,343 shares during the period. DENTSPLY SIRONA comprises about 0.8% of Fuller & Thaler Asset Management Inc.'s investment portfolio, making the stock its 21st biggest holding. Fuller & Thaler Asset Management Inc. owned about 5.81% of DENTSPLY SIRONA worth $219,018,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the company. Vanguard Group Inc. lifted its position in shares of DENTSPLY SIRONA by 0.3% in the 4th quarter. Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier's stock worth $383,078,000 after buying an additional 65,478 shares during the last quarter. First Eagle Investment Management LLC raised its stake in DENTSPLY SIRONA by 2.5% during the fourth quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier's stock worth $275,218,000 after acquiring an additional 348,532 shares during the period. Nuance Investments LLC lifted its holdings in DENTSPLY SIRONA by 25.0% in the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock worth $257,103,000 after acquiring an additional 2,708,097 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its stake in DENTSPLY SIRONA by 18.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier's stock valued at $238,186,000 after acquiring an additional 1,975,404 shares during the period. Finally, Cooke & Bieler LP boosted its stake in DENTSPLY SIRONA by 24.3% in the fourth quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier's stock valued at $174,101,000 after acquiring an additional 1,794,391 shares during the period. 95.70% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier acquired 15,142 shares of DENTSPLY SIRONA stock in a transaction dated Monday, March 3rd. The stock was acquired at an average cost of $16.51 per share, with a total value of $249,994.42. Following the purchase, the director now directly owns 81,971 shares in the company, valued at $1,353,341.21. The trade was a 22.66 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.52% of the company's stock.

Wall Street Analyst Weigh In

Several analysts recently issued reports on XRAY shares. Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a report on Thursday, March 13th. Barrington Research cut their target price on DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating on the stock in a research note on Friday, February 28th. StockNews.com lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a research report on Friday, February 28th. Wells Fargo & Company cut their price objective on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a research report on Friday, February 28th. Finally, Mizuho decreased their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a research report on Thursday, March 13th. Thirteen investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $22.58.

Read Our Latest Stock Report on XRAY

DENTSPLY SIRONA Trading Up 1.6 %

Shares of DENTSPLY SIRONA stock opened at $13.02 on Wednesday. The business has a fifty day simple moving average of $15.38 and a 200-day simple moving average of $18.52. DENTSPLY SIRONA Inc. has a fifty-two week low of $12.16 and a fifty-two week high of $31.00. The firm has a market cap of $2.59 billion, a price-to-earnings ratio of -6.29, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72.

DENTSPLY SIRONA Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Stockholders of record on Friday, March 28th were given a dividend of $0.16 per share. The ex-dividend date was Friday, March 28th. This represents a $0.64 annualized dividend and a dividend yield of 4.92%. DENTSPLY SIRONA's dividend payout ratio (DPR) is -14.07%.

DENTSPLY SIRONA Company Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Articles

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in DENTSPLY SIRONA Right Now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets in Rally Mode: Will Earnings Keep It Going?
3 Tech Stocks to Buy Now—And 3 You’ll Regret Keeping
After Stellar Earnings, Is TSMC the Next Chip Leader?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines